Note that this post ¿Qué son las células madre? is one of our “Stem Cells Not Lost in Translation” series. You can see the full 2020 series of our stem cell white paper in 34 languages here. ¿Qué son las células madre? El cuerpo humano contiene cientos de diferentes tipos de células que son importantes […]
¿Qué son las células madre? Read More »
CIRM announced two sets of awards today that both should make major impact including its first clinical trial via Geron and $38 million for 27 basic biology studies. First Clinical Trial. Today CIRM awarded $25 million to support Geron’s FDA-approved clinical trial for spinal cord injury. This is CIRM’s first award to a for-profit company
CIRM funds $25 million for Geron trial, $38 million for basic biology Read More »
Now and then we will revisit some of our most popular posts and/or posts with the most comments. One of the best: The Monster Tumor: What is a teratoma really? You can go to the link above to read the original post and comments but I’ve pasted the post itself below. In stem cell research
Greatest hits: What is a teratoma? Read More »
The tragic 9.0 earthquake and tsunamis that hit Japan a few weeks ago are having lasting consequences not only for Japan, but also for the world via radiation. One area of particular concern is the radiation that has leaked and is continuing to leak from the damaged nuclear reactors. At this point, the radiation
A reality check on the radiation spreading across the globe Read More »
In it’s first five years in existence, CIRM has awarded almost $1.2 billion for stem cell research in the state of California in the form of just over 400 grants. To give you some perspective on that amount of research funding, let’s compare this CIRM funding to NIH funding for stem cell research across the
The Amazing Path of CIRM in its first 5 years Read More »
There is a kind of invisible cultural wall between patients such as cancer patients and biomedical scientists like me, but this wall does not have to exist and indeed it is a negative wall as patients, scientists, doctors, agencies, and advocates can achieve far more together than apart. But the wall is surprisingly strong. Last
My Cancer: how I became an advocate too Read More »
The DC Appeals Court hears oral arguments today in the case over whether the federal government can legally fund embryonic stem cell (ESC) research. At stake are dozens of research projects that could provide treatments or cures for millions of Americans. Reportedly, an amicus brief to the court has been filed on behalf of Associate
The FDA has given Advanced Cell Technology (ACT) the go ahead to begin their clinical trial using retinal progenitor cells derived from hESC by clearing the company’s IND application, bringing hope to those with vision loss and even blindness. The trial will be a combined Phase I/II to treat Stargardt’s Macular Dystrophy and has huge
One question I am frequently asked by readers and colleagues is “what other stem cell blogs or bloggers can you recommend that are written by a stem cell scientist and updated on a regular basis?” The simple but surprising answer: there are none. It’s lonely out here in cyberspace! (2020 update: The good news today
How many scientist bloggers does it take to change a light bulb? Read More »
Dr. James Sherley, the scientist behind the lawsuit against federally-funded ES cell research, has penned an opinion piece in The Daily Caller today calling on NIH to, in his words, ‘do the right thing.’ However, what Sherley is really asking is for the NIH, other stem cell scientists, and all Americans to think like he
James Sherley of anti-ESC lawsuit calls on NIH to think like he does Read More »